Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ME |
---|---|---|
09:32 ET | 10744 | 3.15 |
09:33 ET | 1800 | 3.164 |
09:35 ET | 1333 | 3.19 |
09:37 ET | 1934 | 3.27 |
09:39 ET | 5158 | 3.298 |
09:42 ET | 6009 | 3.26 |
09:44 ET | 500 | 3.23 |
09:48 ET | 7326 | 3.31 |
09:50 ET | 10942 | 3.365 |
09:51 ET | 13390 | 3.28 |
09:53 ET | 200 | 3.31 |
09:55 ET | 1429 | 3.31 |
09:57 ET | 573 | 3.318 |
10:00 ET | 2983 | 3.3636 |
10:02 ET | 1219 | 3.32 |
10:04 ET | 3067 | 3.33 |
10:06 ET | 891 | 3.358 |
10:08 ET | 1862 | 3.3386 |
10:09 ET | 200 | 3.333 |
10:13 ET | 850 | 3.345 |
10:15 ET | 3788 | 3.37 |
10:18 ET | 881 | 3.365 |
10:20 ET | 400 | 3.36 |
10:22 ET | 7212 | 3.33 |
10:24 ET | 358 | 3.33 |
10:26 ET | 148 | 3.35 |
10:29 ET | 3334 | 3.31 |
10:31 ET | 1905 | 3.32 |
10:36 ET | 3532 | 3.27 |
10:40 ET | 200 | 3.27 |
10:44 ET | 100 | 3.285 |
10:45 ET | 250 | 3.2707 |
10:51 ET | 333 | 3.27 |
10:54 ET | 400 | 3.28 |
10:56 ET | 563 | 3.2701 |
10:58 ET | 3013 | 3.27 |
11:00 ET | 1397 | 3.29 |
11:02 ET | 388 | 3.3 |
11:05 ET | 1200 | 3.3 |
11:07 ET | 354 | 3.3 |
11:14 ET | 1950 | 3.305 |
11:16 ET | 100 | 3.305 |
11:20 ET | 100 | 3.305 |
11:21 ET | 400 | 3.305 |
11:23 ET | 200 | 3.305 |
11:27 ET | 750 | 3.31 |
11:30 ET | 3000 | 3.34 |
11:32 ET | 613 | 3.325 |
11:34 ET | 1300 | 3.36 |
11:36 ET | 302 | 3.36 |
11:41 ET | 500 | 3.34 |
11:54 ET | 392 | 3.35 |
11:56 ET | 213 | 3.37 |
11:59 ET | 2000 | 3.3531 |
12:01 ET | 1000 | 3.345 |
12:08 ET | 200 | 3.345 |
12:10 ET | 600 | 3.345 |
12:12 ET | 6905 | 3.38 |
12:14 ET | 300 | 3.37 |
12:17 ET | 100 | 3.38 |
12:35 ET | 1350 | 3.371 |
12:37 ET | 1791 | 3.38 |
12:39 ET | 300 | 3.365 |
12:48 ET | 899 | 3.37 |
12:50 ET | 187 | 3.385 |
12:57 ET | 200 | 3.38 |
01:02 ET | 4062 | 3.36 |
01:04 ET | 100 | 3.3501 |
01:08 ET | 812 | 3.35 |
01:09 ET | 800 | 3.35 |
01:11 ET | 209 | 3.34 |
01:13 ET | 200 | 3.3401 |
01:15 ET | 300 | 3.35 |
01:22 ET | 5000 | 3.3401 |
01:24 ET | 250 | 3.3301 |
01:26 ET | 100 | 3.3439 |
01:27 ET | 800 | 3.33 |
01:29 ET | 7865 | 3.33 |
01:33 ET | 11841 | 3.32 |
01:36 ET | 1072 | 3.29 |
01:44 ET | 300 | 3.27 |
01:45 ET | 444 | 3.2957 |
01:47 ET | 1390 | 3.2734 |
01:49 ET | 208 | 3.2775 |
01:51 ET | 440 | 3.28 |
01:58 ET | 856 | 3.26 |
02:00 ET | 500 | 3.26 |
02:02 ET | 551 | 3.26 |
02:05 ET | 1500 | 3.2876 |
02:16 ET | 250 | 3.265 |
02:18 ET | 250 | 3.25 |
02:25 ET | 1533 | 3.26 |
02:27 ET | 100 | 3.27 |
02:32 ET | 200 | 3.27 |
02:39 ET | 2350 | 3.27 |
02:43 ET | 200 | 3.27 |
02:45 ET | 200 | 3.285 |
02:50 ET | 600 | 3.2681 |
02:52 ET | 1135 | 3.25 |
02:59 ET | 1600 | 3.24 |
03:06 ET | 3267 | 3.21 |
03:08 ET | 805 | 3.21 |
03:10 ET | 321 | 3.22 |
03:14 ET | 1348 | 3.23 |
03:15 ET | 100 | 3.22 |
03:17 ET | 1152 | 3.23 |
03:19 ET | 302 | 3.2401 |
03:21 ET | 10405 | 3.26 |
03:24 ET | 1698 | 3.265 |
03:26 ET | 4239 | 3.26 |
03:28 ET | 2540 | 3.2705 |
03:30 ET | 1930 | 3.28 |
03:32 ET | 4661 | 3.29 |
03:33 ET | 3264 | 3.31 |
03:37 ET | 1210 | 3.3 |
03:42 ET | 2600 | 3.2675 |
03:44 ET | 11021 | 3.225 |
03:46 ET | 1307 | 3.225 |
03:48 ET | 1338 | 3.26 |
03:50 ET | 833 | 3.24 |
03:51 ET | 1768 | 3.23 |
03:53 ET | 1193 | 3.22 |
03:55 ET | 3051 | 3.2201 |
03:57 ET | 1660 | 3.215 |
04:00 ET | 7608 | 3.23 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
23andMe Holding Co. | 75.9M | -0.1x | --- |
American Well Corp | 120.1M | -0.6x | --- |
Exagen Inc | 73.0M | -4.2x | --- |
Auna SA | 520.4M | -7.9x | --- |
Cryo-Cell International Inc | 63.4M | -7.7x | --- |
Nutex Health Inc | 164.9M | -3.6x | --- |
23andMe Holding Co. is a genetics-led consumer healthcare and biopharmaceutical company. The Company operates through two segments: Consumer & Research Services and Therapeutics. The Consumer & Research Services business segment comprises its Personal Genome Service (PGS), telehealth business, and research service. PGS services provide customers with a broad suite of genetic reports, including information on customers’ genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. The Therapeutics business segment focuses on the use of genetic insights from databases of genetic and phenotypic information to develop novel therapies to improve patients’ lives. The Therapeutics segment consists of out-licensing of intellectual property associated with identified drug targets and expenses related to therapeutic product candidates.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $75.9M |
---|---|
Revenue (TTM) | $193.3M |
Shares Outstanding | 24.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.18 |
EPS | $-25.27 |
Book Value | $7.69 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | 0.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -324.02% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.